R629Q
Category 4 — Stable Fold, Function DisruptedConflictingTransmembrane · predictedEditorialArg→Gln p629 loop AM=0.09 ddg=-0.63 pLDDT=60. ClinVar Conflicting evidence. Atlas mechanism: see structural analysis.
Interactive 3D Structure
Bond changes · DynaMut2 interaction analysis
| Interaction type | Wild-type partner | Mutant partner | Status |
|---|---|---|---|
| Hydrogen bond | S626 | S626 | Preserved |
| Hydrogen bond | M632 | M632 | Preserved |
| Polar contact | S626 | S626 | Preserved |
| Polar contact | L627 | L627 | Preserved |
| Polar contact | S631 | S631 | Preserved |
| Polar contact | M632 | M632 | Preserved |
| Van der Waals | L627 | L627 | Preserved |
| Van der Waals | S631 | — | Lost |
Lost / gained / preserved interatomic contacts at the variant residue, from the DynaMut2 (Arpeggio) interaction analysis of the wild-type and energy-minimized mutant structures.
Computational Predictions
Clinical Evidence
Observed at very low frequency in gnomAD.
Structural Context
Position analysis: THR628 (2.5 Å — same R629 microregion as R629W), SER630 (2.5 Å), SER626 (3.8 Å). Same position as R629W (AM under-call sister). The Atlas's neighbor extraction surfaces this variant's contacts.
Druggability Assessment
Why this matters
Feed this card to Wolfram Intelligence
Download the R629Q PDF below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals — guanidinium mimetics, sigma-1 agonist docking, NAC thiol-capping. NAC is already on the bench-testing list.